Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Genet Mol Res ; 13(3): 7246-55, 2014 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-25222229

RESUMEN

This study aimed to investigate the influence of acute glycemic load on vascular endothelial function in patients with hypertension and to evaluate the protective effect of vitamins C and E during the acute glycemic phase. We randomly selected 39 hypertensive patients and 21 normal subjects and divided them into 3 groups: 75 g oral glucose (glycemic load group), 75 g glucose+0.9 g vitamin C (VC group), 75 g glucose+2 g vitamin C+0.8 g vitamin E (VC+VE group). Extravascular color Doppler ultrasound was used to detect brachial artery flow-mediated vasodilation at 0, 1, 2, and 3 h, and, at the same time, serum anti-oxidant products were measured. Basic endothelial functions in patients with hypertension were decreased in the glycemic load group (9.48±3.33 versus 13.09±6.78%, P<0.05), and was even more depressed in the hypertensive group (9.48±3.33 versus 14.20±6.48%, P<0.05). Antioxidant vitamins played a dose-dependent protective role on acute damage of endothelial function due to glycemic load. Acute high blood sugar damaged vascular endothelial functions, especially in hypertensive patients, but this effect can be reversed by large doses of vitamin C and E.


Asunto(s)
Ácido Ascórbico/uso terapéutico , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiopatología , Hipertensión/tratamiento farmacológico , Hipertensión/fisiopatología , Vitamina E/uso terapéutico , Adulto , Antioxidantes/metabolismo , Ácido Ascórbico/administración & dosificación , Glucemia , Estudios de Cohortes , Hipertensión Esencial , Femenino , Glucosa/administración & dosificación , Glucosa/efectos adversos , Humanos , Hipertensión/sangre , Hipertensión/etiología , Masculino , Persona de Mediana Edad , Factores de Riesgo , Superóxido Dismutasa/sangre , Superóxidos/sangre , Vasodilatación/efectos de los fármacos , Vitamina E/administración & dosificación
2.
Genet Mol Res ; 12(4): 6692-707, 2013 Dec 13.
Artículo en Inglés | MEDLINE | ID: mdl-24391011

RESUMEN

An inflammatory response induced by high glucose is a cause of endothelial dysfunction in diabetes and is an important contributing link to atherosclerosis. Diabetes is an independent risk factor of atherosclerosis and activation of retinoid X receptor (RXR) has been shown to exert anti-atherogenic effects. In the present study, we examined the effects of the RXR ligands 9-cis-retinoic acid (9-cis-RA) and SR11237 on high glucose-induced inflammation in human umbilical endothelial vein endothelial cells (HUVECs) and explored the potential mechanism. Our results showed that the inflammation induced by high-glucose in HUVECs was mainly mediated by the activation of nuclear factor-B (NF- κB). High glucose-induced expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) were in comparison, significantly decreased by treatment with RXR. The effect of RXR agonists was mainly due to the inhibition of NF-κB activation. Using pharmacological inhibitors and siRNA, we confirmed that nicotinamide adenine dinucleotide phosphate (NADPH) oxidase was an upstream activator of NF-κB. Furthermore, RXR agonists significantly inhibited high glucose-induced activation of NADPH oxidase and significantly decreased the production of reactive oxygen species (ROS). To explore whether the rapid inhibitory effects of RXR agonists were in fact mediated by RXR, we examined the effect of RXR downregulation by RXR siRNA. Our results showed that RXR siRNA largely abrogated the effects of RXR agonists, suggesting the requirement of RXR expression. Therefore, we have shown that RXR is involved in the regulation of NADPH oxidase- NF-κB signal pathway, as the RXR ligands antagonized the inflammatory response in HUVECs induced by high glucose.


Asunto(s)
Glucosa/farmacología , Inflamación/inmunología , NADPH Oxidasas/antagonistas & inhibidores , Receptores X Retinoide/agonistas , Factor de Transcripción ReIA/antagonistas & inhibidores , Alitretinoína , Antineoplásicos/farmacología , Aterosclerosis , Benzoatos/farmacología , Células Cultivadas , Diabetes Mellitus , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Glucosa/inmunología , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , Inflamación/tratamiento farmacológico , Molécula 1 de Adhesión Intercelular/biosíntesis , NADPH Oxidasa 4 , NADPH Oxidasas/genética , Interferencia de ARN , ARN Interferente Pequeño , Especies Reactivas de Oxígeno/metabolismo , Receptores X Retinoide/genética , Receptores X Retinoide/farmacología , Retinoides/farmacología , Tretinoina/farmacología , Regulación hacia Arriba , Molécula 1 de Adhesión Celular Vascular/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA